@becominglashonda's GLP-1 appetite claims, fact-checked

What did @becominglashonda actually say?

She described finding a point in her GLP-1 journey where she has "no interest" in eating. Over two days, she consumed only a protein shake and peanut butter. She framed this as a positive milestone, a place where she "don't care to eat." That framing is worth examining carefully, because there's a meaningful difference between reduced appetite and near-total food aversion.

To be fair, she's describing a real, documented effect of GLP-1 receptor agonists like tirzepatide. These medications do suppress appetite, sometimes dramatically. But two days of minimal intake isn't a badge of honor. It's a clinical signal that deserves attention, not celebration on social media.

Does the science back this up?

Yes and no. Appetite suppression is real and well-documented, but the degree she's describing crosses into a risk zone that the trials flagged repeatedly.

Tirzepatide works on both GIP and GLP-1 receptors, which gives it a stronger appetite-suppressing effect than semaglutide alone. In the SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine), participants on tirzepatide lost significant weight, but the trial also tracked adverse events carefully. Nausea, vomiting, and reduced appetite were among the most common side effects, and they were dose-dependent. Critically, the trial protocol included dietary counseling specifically because inadequate nutrition is a real risk on these medications.

When appetite suppression becomes severe enough that someone eats almost nothing for two days, you're looking at potential muscle loss, micronutrient deficiency, and in some cases, dangerous caloric restriction that can stress the heart and other organs. A protein shake and peanut butter is not a nutritional plan. It's what happens when the medication is doing more than the person is managing.

What did they get wrong (or right)?

She got the basic phenomenon right. GLP-1 and dual GIP/GLP-1 agonists do reduce food noise and appetite. That part is accurate and well-supported. Some patients do describe a shift where eating feels functional rather than emotional, and researchers have studied this. Blum et al. (2021, Obesity) found that semaglutide reduced food cue reactivity and what patients described as intrusive food thoughts. That experience is real.

What she got wrong is the framing. Presenting near-zero food intake over 48 hours as a milestone rather than a warning sign is the problem. Adequate protein intake is especially important on GLP-1 medications because rapid weight loss increases the risk of losing lean muscle mass. Cava et al. (2017, Nutrients) reviewed how very low calorie intake during weight loss accelerates muscle catabolism without sufficient protein. A single protein shake does not clear that bar.

There's also no mention of hydration, electrolytes, or whether she's spoken to a prescriber about this level of suppression. That absence matters.

What should you actually know?

If you're on a GLP-1 medication and find yourself going 48 hours on minimal food, that is not the goal. It is a side effect that needs to be managed, and in some cases, it's a reason to contact your prescriber about adjusting your dose.

Clinical guidelines from the Obesity Medicine Association recommend that patients on GLP-1 medications prioritize protein intake of at least 1.2 grams per kilogram of body weight to preserve lean mass during weight loss. "Eating because you need to, not because you want to" is only healthy if you are actually eating enough to meet your needs.

Here's what the evidence supports as appropriate:

• Reduced appetite is expected and can be a useful therapeutic effect
• Complete food aversion lasting more than a day is a side effect, not a feature
• Protein and hydration goals still apply, even when you're not hungry
• Dose titration exists partly to manage this, if suppression is too severe, your prescriber can adjust
• Social media framing of extreme restriction as success can cause real harm to people who take it as a template

The medication is doing something real. Managing it responsibly is the actual work.